RNA interference-mediated silencing of the fatty acid synthase gene attenuates growth and induces morphological changes and apoptosis of LNCaP prostate cancer cells

Cancer Research

Volumn 63, Issue 13, 2003, Pages 3799-3804

  De Schrijver, Ellen ^a   Brusselmans, Koen ^a   Heyns, Walter ^a   Verhoeven, Guido ^a   Swinnen, Johannes V ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID SYNTHASE; RNA;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER THERAPY; CELL CONTACT; CELL VIABILITY; CELL VOLUME; ENZYME INHIBITION; FATTY ACID SYNTHESIS; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE SILENCING; GROWTH RATE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROSTATE CANCER; SKIN FIBROBLAST;

APOPTOSIS; CELL DIVISION; FATTY ACID SYNTHETASE COMPLEX; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENETIC MARKERS; HUMANS; LUCIFERASES; LYMPH NODES; MALE; PROSTATIC NEOPLASMS; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 0038418257     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Wakil, S. J. Fatty acid synthase, a proficient multifunctional enzyme. Biochemistry, 28: 4523-4530, 1989.
2. Weiss, L., Hoffmann, G. E., Schreiber, R., Andres, H., Fuchs, E., Korber, E., and Kolb, H. J. Fatty-acid biosynthesis in man, a pathway of minor importance. Purification, optimal assay conditions, and organ distribution of fatty-acid synthase. Biol. Chem. Hoppes-Seyer, 367: 905-912, 1986.
3. Kuhajda, F. P. Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology. Nutrition, 16: 202-208, 2000.
4. Piyathilake, C. J., Frost, A. R., Manne, U., Bell, W. C., Weiss, H., Heimburger, D. C., and Grizzle, W. E. The expression of fatty acid synthase (FASE) is an early event in the development and progression of squamous cell carcinoma of the lung. Hum. Pathol., 31: 1068-1073, 2000.
5. Swinnen, J. V., Roskams, T., Joniau, S., Van Poppel, H., Oyen, R., Baert, L., Heyns, W., and Verhoeven, G. Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer. Int. J. Cancer., 98: 19-22, 2002.
6. Kusakabe, T., Nashimoto, A., Honma, K., and Suzuki, T. Fatty acid synthase is highly expressed in carcinoma, adenoma and in regenerative epithelium and intestinal metaplasia of the stomach. Histopathology, 40: 71-79, 2002.
7. Swinnen, J. V., Vanderhoydonc, F., Elgamal, A. A., Eelen, M., Vercaeren, M., Joniau, S., Van Poppel, H., Baert, L., Goossens, K., Heyns, W., and Verhoeven, G. Selective activation of the fatty acid synthesis pathway in human prostate cancer. Int. J. Cancer, 88: 176-179, 2000.
8. Swinnen, J. V., Heemers, H., Deboel, L., Foufelle, F., Heyns, W., and Verhoeven, G. Stimulation of tumor-associated fatty acid synthase expression by growth factor activation of the sterol regulatory element-binding protein pathway. Oncogene, 19: 5173-5181, 2000.
9. Li, J. N., Mahmoud, M. A., Han, W. F., Ripple, M., and Pizer, E. S. Sterol regulatory element-binding protein-1 participates in the regulation of fatty acid synthase expression in colorectal neoplasia. Exp. Cell Res., 261: 159-165, 2000.
10. Swinnen, J. V., Esquenet, M., Goossens, K., Heyns, W., and Verhoeven, G. Androgens stimulate fatty acid synthase in the human prostate cancer cell line LNCaP. Cancer Res., 57: 1086-1090, 1997.
11. Swinnen, J. V., Ulrix, W., Heyns, W., and Verhoeven, G. Coordinate regulation of lipogenic gene expression by androgens: evidence for a cascade mechanism involving sterol regulatory element binding proteins. Proc. Natl. Acad. Sci. USA, 94: 12975-12980, 1997.
12. Heemers, H., Maes, B., Foufelle, F., Heyns, W., Verhoeven, G., and Swinnen, J. V. Androgens stimulate lipogenic gene expression in prostate cancer cells by activation of the sterol regulatory element-binding protein cleavage activating protein/sterol regulatory element-binding protein pathway. Mol. Endocrinol., 15: 1817-1828, 2001.
13. Van de Sande, T., De Schrijver, E., Heyns, W., Verhoeven, G., and Swinnen, J. V. Role of the phosphatidylinositol 3′-kinase/PTEN/Akt kinase pathway in the overexpression of fatty acid synthase in LNCaP prostate cancer cells. Cancer Res., 62: 642-646, 2002.
14. Yang, Y., Han, W., Morin, P., Chrest, F., and Pizer, E. Activation of fatty acid synthesis during neoplastic transformation: role of mitogen-activated protein kinase and phosphatidylinositol 3-kinase. Exp. Cell Res., 279: 80-90, 2002.
15. Lacasa, D., Le Liepvre, X., Ferre, P., and Dugail, I. Progesterone stimulates adipocyte determination and differentiation I/sterol regulatory element-binding protein Ic gene expression, potential mechanism for the lipogenic effect of progesterone in adipose tissue. J. Biol. Chem., 276: 11512-11516, 2001.
16. Chalbos, D., Joyeux, C., Galtier, F., and Rochefort, H. Progestin-induced fatty acid synthetase in human mammary tumors: from molecular to clinical studies. J. Steroid Biochem. Mol. Biol., 43: 223-228, 1992.
17. Pizer, E. S., Chrest, F. J., DiGiuseppe, J. A., and Han, W. F. Pharmacological inhibitors of mammalian fatty acid synthase suppress DNA replication and induce apoptosis in tumor cell lines. Cancer Res., 58: 4611-4615, 1998.
18. Kuhajda, F. P., Pizer, E. S., Li, J. N., Mani, N. S., Frehywot, G. L., and Townsend, C. A. Synthesis and antitumor activity of an inhibitor of fatty acid synthase. Proc. Natl. Acad. Sci. USA, 97: 3450-3454, 2000.
19. Liu, B., Wang, Y., Fillgrove, K. L., and Anderson, V. E. Triclosan inhibits enoylreductase of type I fatty acid synthase in vitro and is cytotoxic to MCF-7 and SKBr-3 breast cancer cells. Cancer Chemother. Pharmacol., 49: 187-193, 2002.
20. Pizer, E. S., Wood, F. D., Heine, H. S., Romantsev, F. E., Pasternack, G. R., and Kuhajda, F. P. Inhibition of fatty acid synthesis delays disease progression in a xenograft model of ovarian cancer. Cancer Res., 56: 1189-1193, 1996.
21. Pizer, E. S., Jackisch, C., Wood, F. D., Pasternack, G. R., Davidson, N. E., and Kuhajda, F. P. Inhibition of fatty acid synthesis induces programmed cell death in human breast cancer cells. Cancer Res., 56: 2745-2747, 1996.
22. Li, J. N., Gorospe, M., Chrest, F. J., Kumaravel, T. S., Evans, M. K., Han, W. F., and Pizer, E. S. Pharmacological inhibition of fatty acid synthase activity produces both cytostatic and cytotoxic effects modulated by p53. Cancer Res., 61: 1493-1499, 2001.
23. Jochen, A. L., Hays, J., and Mick, G. Inhibitory effects of cerulenin on protein palmitoylation and insulin internalization in rat adipocytes. Biochim. Biophys. Acta, 1259: 65-72, 1995.
24. Lawrence, D. S., Zilfou, J. T., and Smith, C. D. Structure-activity studies of cerulenin analogues as protein palmitoylation inhibitors. J. Med. Chem., 42: 4932-4941, 1999.
25. Malvoisin, E., and Wild, F. Effect of drugs which inhibit cholesterol synthesis on syncytia formation in vero cells infected with measles virus. Biochim. Biophys. Acta, 1042: 359-364, 1990.
26. Goldfine, H., Harley, J. B., and Wyke, J. A. Effects of inhibitors of lipid synthesis on the replication of Rous sarcoma virus. A specific effect of cerulenin on the processing of major non-glycosylated viral structural proteins. Biochim. Biophys. Acta, 512: 229-240, 1978.
27. Moelling, K., Schulze, T., Knoop, M. T., Kay, J., Jupp, R., Nicolaou, G., and Pearl, L. H. In vitro inhibition of HIV-1 proteinase by cerulenin. FEBS Lett., 261: 373-377, 1990.
28. Ikuta, K., and Luftig, R. B. Inhibition of cleavage of Moloney murine leukemia virus gag and env coded precursor polyproteins by cerulenin. Virology. 154: 195-206, 1986.
29. Zamore, P. D., Tuschl, T., Sharp, P. A., and Bartel, D. P. RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell, 101: 25-33, 2000.
30. Elbashir, S. M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., and Tuschl, T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature (Lond.), 411: 494-498, 2001.
31. Harborth, J., Elbashir, S. M., Bechert, K., Tuschl, T., and Weber, K. Identification of essential genes in cultured mammalian cells using small interfering RNAs. J. Cell Sci., 114: 4557-4565, 2001.
32. Swinnen, J. V., Van Veldhoven, P. P., Esquenet, M., Heyns, W., and Verhoeven, G. Androgens markedly stimulate the accumulation of neutral lipids in the human prostatic adenocarcinoma cell line LNCaP. Endocrinology, 137: 4468-4474, 1996.
33. Goossens, K., Deboel, L., Swinnen, J. V., Roskams, T., Manin, M., Rombauts, W., and Verhoeven, G. Both retinoids and androgens are required to maintain or promote functional differentiation in reaggregation cultures of human prostate epithelial cells. Prostate, 53: 34-49, 2002.
34. Thupari, J. N., Pinn, M. L., and Kuhajda, F. P. Fatty acid synthase inhibition in human breast cancer cells leads to malonyl-CoA-induced inhibition of fatty acid oxidation and cytotoxicity. Biochem. Biophys. Res. Commun., 285: 217-223, 2001.
35. Pizer, E. S., Thupari, J., Han, W. F., Pinn, M. L., Chrest, F. J., Frehywot, G. L., Townsend, C. A., and Kuhajda, F. P. Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced by fatty-acid synthase inhibition in human breast cancer cells and xenografts. Cancer Res., 60: 213-218, 2000.
36. Wilda, M., Fuchs, U., Wossmann, W., and Borkhardt, A. Killing of leukemic cells with a BCR/ABL fusion gene by RNA interference (RNAi). Oncogene, 21: 5716-5724, 2002.
37. Jiang, M., and Milner, J. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference. Oncogene, 21: 6041-6048, 2002.
38. Borkhardt, A. Blocking oncogenes in malignant cells by RNA interference: new hope for a highly specific cancer treatment? Cancer Cells, 2: 167-168, 2002.
39. Brummelkamp, T. R., Bernards, R., and Agami, R. Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cells, 2: 243-247, 2002.